Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 7, 2023; 29(13): 1969-1981
Published online Apr 7, 2023. doi: 10.3748/wjg.v29.i13.1969
Published online Apr 7, 2023. doi: 10.3748/wjg.v29.i13.1969
Ref. | Country | Design | Tumour anatomical subtype | Treatments (s) | Total patients (n) | Median follow-up/yr (range) | Outcomes (5-year)1 | ||
Overall survival (%) | Disease free survival (%) | Graft survival (%) | |||||||
Azad et al[28], 2020 | United States | Retrospective, single centre | Perihilar | Neoadjuvant chemo-radiotherapy and LT | De novo: 148, PSC: 228 | - | De novo: 58 KM, PSC: 74 KM | De novo: 55 KM, PSC: 78 KM | - |
Darwish Murad et al[36], 2012 | United States | Retrospective, multi-centre | Perihilar | Neoadjuvant chemo-radiotherapy and LT | 287 | 2.5 (0.1-17.8) | 53 KM | 65 KM | 60 KM |
Hidalgo et al[37], 2008 | United Kingdom | Retrospective, single centre | Perihilar | LT | 12 | 1.81 | 41 KM | - | - |
Robles et al[38], 2004 | Spain | Retrospective, multi-centre | Perihilar | LT | 36 | - | 64 | 47 | - |
Ethun et al[14], 2018 | United States | Retrospective, multi-centre | Perihilar | Neoadjuvant chemo-radiotherapy and LT | 70 | 4.83 (0.025-10.6) | 64 KM | 24 KM | - |
Krasnodębski et al[47], 2020 | Poland | Retrospective, multi-centre | Intrahepatic | LT | 8 | 30 | 25 | 28.6 | - |
Lee et al[48], 2018 | United States | Retrospective, single centre | Intrahepatic | Neoadjuvant TARE/TACE/RFA and LT | 17 | Mean 4.2 | 51.9 | 70.6 | - |
Sapisochin et al[50], 2014 | Spain | Retrospective, multi-centre | Intrahepatic | Neoadjuvant ethanol injection/TACE/RFA and LT | 27 | 4.99 (0.97-11.9) | 51 | 36 | - |
Sapisochin et al[51], 2016 | International | Retrospective, multi-centre | Intrahepatic- early1 and advanced | Neoadjuvant ethanol injection/TACE/RFA and LT | Early1-15, Advanced-33 | Early-4.78, Advanced-2.06 | Early-65, Advanced-45 | Early-86.7, Advanced-48.5 | - |
Hue et al[54], 2021 | United States | Retrospective, multi-centre | Intrahepatic | Neoadjuvant chemo-radiation and LT | 74 | 3.9 | 33 KM | - | - |
Lunsford et al[55], 2018 | United States | Prospective, single centre | Intrahepatic | Neoadjuvant chemotherapy and LT | 6 | 3 (2.42-4.25) | 83.3 | 50 | 100 |
Wong et al[56], 2019 | United States | Prospective, single centre | Intrahepatic | Neoadjuvant chemotherapy and TACE and LT | 5 | 1.84 | 80 | 60 | - |
- Citation: Borakati A, Froghi F, Bhogal RH, Mavroeidis VK. Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances. World J Gastroenterol 2023; 29(13): 1969-1981
- URL: https://www.wjgnet.com/1007-9327/full/v29/i13/1969.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i13.1969